Open access
Open access
Powered by Google Translator Translator

Critical Care & Emergencies (all articles)

[Abstract Only] Meta-Analysis: Delayed vs. Early Initiation of Renal Replacement Therapy for Severe Acute Kidney Injury

26 Apr, 2020 | 21:15h | UTC

Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-analysis of randomised clinical trials – The Lancet

 


NICE COVID-19 Rapid Guideline: Acute Myocardial Injury

24 Apr, 2020 | 03:50h | UTC

COVID-19 rapid guideline: acute myocardial injury – National Institute for Health and Care Excellence

Related Guidelines: ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic – European Society of Cardiology AND Management of Acute Myocardial Infarction During the COVID-19 Pandemic – Journal of the American Academy of Cardiology

 


Respiratory Support in Novel Coronavirus Disease (COVID-19) Patients, with a Focus on Resource-Limited Settings

24 Apr, 2020 | 03:48h | UTC

Respiratory Support in Novel Coronavirus Disease (COVID-19) Patients, with a Focus on Resource-Limited Settings – The American Society of Tropical Medicine and Hygiene

 


Observational Study: Renin-Angiotensin System Inhibitors are Not Associated with Severity or Mortality in Hospitalized Patients with Coronavirus Disease

24 Apr, 2020 | 03:46h | UTC

Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China – JAMA Cardiology

Commentary: Drugs for high blood pressure don’t appear to make COVID-19 worse – Science News

Related Study: Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19 – Circulation Research

 


Perspective: Against Pandemic Research Exceptionalism

24 Apr, 2020 | 03:39h | UTC

Against pandemic research exceptionalism – Science

“Crises are no excuse for lowering scientific standards.”

 


Debate: Is it Wrong to Prioritize Younger Patients with Covid-19?

24 Apr, 2020 | 03:30h | UTC

Is it wrong to prioritise younger patients with covid-19? – The BMJ

Commentary: Should age be a prioritizing factor in deciding who gets treated for COVID-19? – News Medical

 


Perspective: In Defense of Evidence-Based Medicine for the Treatment of COVID-19 ARDS

24 Apr, 2020 | 03:36h | UTC

In Defense of Evidence-Based Medicine for the Treatment of COVID-19 ARDS – Annals of the American Thoracic Society

 


New Data on Remdesivir: No benefit for Patients with Covid-19

24 Apr, 2020 | 03:31h | UTC

New data on Gilead’s remdesivir, released by accident, show no benefit for coronavirus patients. Company still sees reason for hope – STAT

Related: Remdesivir in covid-19 – The BMJ AND What’s Happening With Remdesivir? – Science Translational Medicine AND Slow down your giddyup on Gilead news – Health News Review

 


Hydroxychloroquine and Coronavirus: A Guide to the Scientific Studies so Far

24 Apr, 2020 | 03:28h | UTC

Hydroxychloroquine and coronavirus: a guide to the scientific studies so far – The Guardian

 


Clinical Features and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

23 Apr, 2020 | 09:43h | UTC

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area – JAMA

Commentary: Almost Every Hospitalized Coronavirus Patient Has Another Underlying Health Issue, According to a Study of New York Patients – TIME

 


Opinion: A Call for Rational Intensive Care in the Era of COVID-19

23 Apr, 2020 | 09:34h | UTC

A Call for Rational Intensive Care in the Era of COVID-19 – American Journal of Respiratory Cell and Molecular Biology

 


Editorial: Remdesivir in Covid-19

23 Apr, 2020 | 09:35h | UTC

Remdesivir in covid-19 – The BMJ

Related: What’s Happening With Remdesivir? – Science Translational Medicine AND Slow down your giddyup on Gilead news – Health News Review

 


Low-cost, Easy-to-build Non-Invasive Pressure Support Ventilator for Under-resourced Regions: Open Source Hardware Description, Performance and Feasibility Testing

23 Apr, 2020 | 09:26h | UTC

Low-cost, easy-to-build non-invasive pressure support ventilator for under-resourced regions: open source hardware description, performance and feasibility testing – European Respiratory Journal

Commentary: Low-cost, easy-to-build ventilator performs similarly to high-quality commercial device – European Lung Foundation

 


NIH COVID-19 Treatment Guidelines

22 Apr, 2020 | 09:02h | UTC

NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines – National Institutes of Health

News Release: Expert U.S. panel develops NIH treatment guidelines for COVID-19

Commentary: New U.S. Treatment Guidelines for Covid-19 Don’t See Much Progress – The New York Times

 


[Preprint] Observational Study: No Benefit from Hydroxychloroquine in Patients Hospitalized with Covid-19

22 Apr, 2020 | 08:58h | UTC

Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19 – medRxiv

Commentaries: Study finds no benefit, higher death rate in patients taking hydroxychloroquine for Covid-19 – CNN AND More deaths, no benefit from malaria drug in VA virus study – Associated Press

 


ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic

22 Apr, 2020 | 09:00h | UTC

ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic – European Society of Cardiology

 


ACC Consensus Statement: Management of Acute Myocardial Infarction During the COVID-19 Pandemic

21 Apr, 2020 | 08:17h | UTC

Management of Acute Myocardial Infarction During the COVID-19 Pandemic – Journal of the American Academy of Cardiology

Commentaries: ACC, SCAI, ACEP Release Consensus Statement on Management of AMI Patients During COVID-19 – American College of Cardiology

 


Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome

21 Apr, 2020 | 08:15h | UTC

Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome – Circulation

 


Therapeutic Strategies for Critically Ill Patients with COVID-19

21 Apr, 2020 | 08:14h | UTC

Therapeutic strategies for critically ill patients with COVID-19 – Annals of Intensive Care

 


Opinion – Timed & Titrated use of Steroids in COVID-19?

21 Apr, 2020 | 08:11h | UTC

Timed & titrated use of steroid in COVID-19? – PulmCrit

 


D‐dimer Levels on Admission to Predict In‐hospital Mortality in Patients with Covid‐19

21 Apr, 2020 | 08:06h | UTC

D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19 – Journal of Thrombosis and Haemostasis

Related: D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis – Thrombosis and Haemostasis

 


Thrombocytopenia and Its Association with Mortality in Patients with COVID‐19

21 Apr, 2020 | 08:04h | UTC

Thrombocytopenia and Its Association with Mortality in Patients with COVID‐19 – Journal of Thrombosis and Haemostasis

Related: Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis – Clinica Chimica Acta

 


How Does Coronavirus Kill?

20 Apr, 2020 | 00:21h | UTC

How does coronavirus kill? Clinicians trace a ferocious rampage through the body, from brain to toes – Science

 


Review: COVID-19 and Thrombotic or Thromboembolic Disease

20 Apr, 2020 | 00:18h | UTC

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up – Journal of the American College of Cardiology

Commentary: JACC Paper Outlines Implications, Considerations For Thrombotic Disease Patients During COVID-19 Pandemic – American College of Cardiology

 


Priorities for Cath Labs in the COVID-19 Tsunami

20 Apr, 2020 | 00:15h | UTC

Priorities for Cath labs in the COVID-19 tsunami: Roberto Ferrari and co-authors present a procedure to follow subsequent to the outbreak in Italy – European Heart Journal

Commentary: Priorities for Cath Labs in the COVID-19 Tsunami – American College of Cardiology

Related: Reperfusion of STEMI in the COVID-19 Era – Business as Usual? – Circulation AND As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI – TCTMD

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.